Table 2. Logistic regression analysis of development of contrast-induced nephropathy in 100-month follow-up.
| Parameters | Patients developing CIN (n=42) |
Patients not developing CIN (n=176) |
p-value |
|---|---|---|---|
| White blood cell, 103/μL | 10.0±3.5 | 9.6±3.5 | 0.540 |
| Hemoglobin, gr/dL | 13.4±1.9 | 13.6±1.8 | 0.462 |
| Neutrophile, 109/L | 7.1±3.4 | 6.6±3.5 | 0.409 |
| Lymphocyte, 109/L | 1.9±0.86 | 2.1±0.89 | 0.087 |
| Platelet, 103/μL | 251±91 | 245±70 | 0.641 |
| Glucose, mg/dL | 134 (100-254) | 118 (99-187) | 0.389 |
| Creatinine, mg/dL | 1.09±0.32 | 1.00±0.46 | 0.202 |
| Glomerular filtration rate, mL/min | 74.8±25.0 | 82.9±24.5 | 0.058 |
| Sodium, mEq/L | 136.4±3.5 | 135.5±10.5 | 0.576 |
| Potassium, mEq/L | 4.3±0.65 | 4.6±2.6 | 0.459 |
| Albumin, mg/dL | 3.5 (3-3.9) | 3.7 (3.3-3.9) | 0.182 |
| C-reactive protein, mg/dL | 0.62 (0.30-6.8) | 0.38 (0.10-2.5) | 0.029 |
| Total cholesterol, mg/dL | 188±41 | 179±50 | 0.281 |
| HDL, mg/dL | 37.5±7.4 | 40±11 | 0.151 |
| LDL, mg/dL | 117±33.8 | 103±38 | 0.035 |
| Triglyceride, mg/dL | 137 (96-198) | 145 (98-213) | 0.851 |
CIN: contrast-induced nephropathy; HDL: high-density lipoprotein; LDL: low-density lipoprotein. Bold indicates significant value.